Medico Remedies Ltd.

Financial

	Medico Remedies	Lyka Labs	Guj. Themis Biosyn
Operational Metrics
Financials
5 yr Average ROE	9.74 %	143.45 %	42.99 %
5yr average Equity Multiplier	2.35	0.43	1.49
5yr Average Asset Turnover Ratio	1.44	0.57	1.0
5yr Avg Net Profit Margin	2.94 %	-22.76 %	30.73 %
Price to Book	8.11	5.98	16.68
P/E	55.51	0.0	54.01
5yr Avg Cash Conversion Cycle	15.53 Days	1.36 Days	-29.58 Days
Inventory Days	55.17 Days	30.5 Days	20.35 Days
Days Receivable	86.4 Days	75.65 Days	52.71 Days
Days Payable	139.29 Days	141.66 Days	508.85 Days
5yr Average Interest Coverage Ratio	7.33	0.21	117.9
5yr Avg ROCE	14.76 %	20.41 %	55.36 %
5yr Avg Operating Profit Margin	6.57 %	19.78 %	43.76 %
5 yr average Debt to Equity	0.37	-0.51	0.11
5yr CAGR Net Profit	35.76 %	18.94 %	55.33 %
5yr Average Return on Assets	4.38 %	-5.86 %	29.29 %
Shareholdings
Promoter Holding	73.34 %	54.81 %	70.86 %
Share Pledged by Promoters	0.0	0.0	3.3 %
Change in Promoter Holding (3 Yrs)	0.0	34.93 %	-4.13 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.78 %

Business

	Medico Remedies	Lyka Labs	Guj. Themis Biosyn
Product Wise Break-Up	Product Wise Break-Up Manufactured Goods 93.05 Traded Goods 5.57 Formulations 0 Bulk Drugs 0 0 Others 1.38	Product Wise Break-Up Manufactured Goods 0 Formulations 96.8 Traded Goods 0 Bulk Drugs 3.2 0	Product Wise Break-Up Manufactured Goods 0 Formulations 0 Traded Goods 0 Bulk Drugs 0 Pharmaceutical 100.0
Segment Break-Up	Segment Break-Up Pharmaceuticals 100.0	-	-